Commerzbank, Deutsche Bank, ING, Royal Bank of Scotland and Rabobank were each allocated Eu100m of the deal, with Rabobank acting as the coordinator for the refinancing. All five banks were existing lenders on the company’s outstanding facility.
The existing standby loan is not thought to have been drawn since it was signed in 2007 to refinance bilateral lines.
Last April, ASML signed a Eu200m loan with the European Investment Bank to support the company’s extreme ultraviolet product. The loan can be drawn in tranches until this October, and is repayable in annual instalments four years after drawdown, with a final repayment seven years after drawdown. None of the facility had been utilised at the end of last year.
At the end of March, ASML reported a first quarter loss of Eu107.8m. The company had long term debt of Eu705.2m.
